Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

U.S. Markets are not yet open, but PLX is being traded in the pre-market session. Pre-Market quote »
0.84
Delayed Data
As of Feb 05
 +0.04 / +5.00%
Today’s Change
0.74
Today|||52-Week Range
2.35
-17.65%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close0.80
Today’s open0.84
Day’s range0.83 - 0.85
Volume75,664
Average volume (3 months)464,205
Market cap$83.8M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)+256.25%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc-0.01-1.31%
GNCAGenocea Biosciences ...-0.16-5.33%
PTIEPain Therapeutics In...+0.07+4.19%
CFRXContraFect Corp+0.24+7.49%
Data as of 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

Partner Offers